Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Norway / NCT05864547
Recruiting Observational

Predisposing Factors for Post-stroke Epilepsy

NCT05864547 · tracked via the Priya Life Science Norway tracker
Sponsor
Norwegian University of Science and Technology
Phase
Observational
Started
2023-05-08
Last updated
2026-07-07

Condition(s) studied

Post Stroke EpilepsyStrokeEpilepsySeizures

Study summary

The goal of this observational study is to learn about epilepsy after a stroke (post-stroke epilepsy). The main questions it aims to answer are:

* What make some patients develop epilepsy after a stroke?
* Does sleep have an impact on the development of post-stroke epilepsy?

Participants will undergo:

* Electroencephalography (EEG)
* Magnetic resonance imaging (MRI)
* Polysomnography (only patients)

Blood tests will also be taken. The patient group will be compared to the healthy controls. Researchers will also look into medical records of stroke patients hospitalized at St. Olavs hospital and collect relevant information.

Eligibility

Sex
ALL
Min age
18 Years
Max age
85 Years
Healthy volunteers
Accepted
Inclusion Criteria: * First time stroke patients with capacity to consent, admitted to the stroke unit at St. Olavs hospital. * Modified Rankin Scale (mRS) ≤ 2 before the stroke Exclusion Criteria: * Previous stroke or brain surgery * Traumatic brain injuries * Neurodegenerative diseases * Brain tumors * Epilepsy before the stroke * Hydrocephalus * Aphasia * Serious psychiatric disorders * MRI incompatibility and claustrophobia

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
St. Olavs Hospital Stroke Unit Trondheim Norway Recruiting

More Norwegian University of Science and Technology trials in Norway

Multimodal Assesment of Alzheimer Patients Recruiting
Bariatric Surgery and Pharmacokinetics of Metoprolol Recruiting
Bariatric Surgery and Pharmacokinetics of Candesartan Recruiting
Bariatric Surgery and Pharmacokinetics of Ibuprofen Recruiting
Effects of a High-protein Diet and Resistance Training on Fat-mass Loss Maintenance Active, not recruiting

Other trials for the same condition

Decentralized Imaging by REmote Computer Tomography for Cerebral Infarct Thrombolysis Recruiting
Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation Recruiting
Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage Active, not recruiting
Population-based Atrial Fibrillation Screening in Individuals With NT-proBNP Above Median in the Tromsø Study Recruiting
Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05864547 on ClinicalTrials.gov ↗ ← All trials in Norway